No matching stocks found

Take a short break, or try a different search term.

Try widening your filters, clearing the search, or checking another sector.

“Good screens are built by narrowing the noise, not the signal.”

Plutux

Systems Boards Journals Stocks Insights Pricing Resources

SystemsBoardsJournalsStocksInsightsPricingResourcesMore

Prothena Corporation plc

$8.75

+0.92%

N/A+$0.08

Healthcare

Biotechnology

NASDAQ

Active Trading

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein ...

Key Metrics Overview Fundamental Analysis Price Action Financial Highlights Financial Statements Leadership Team CEO Profile Earnings Call Transcripts Recent News Employee Count Key Products Supply Chain Insider Transactions

Key Metrics of PRTA

Loading key metrics...

Loading key metrics...

About Us•Privacy Policy•Terms of Service•Join our Slack

© Plutux Technology Limited 2026

Prothena Corporation plc (PRTA) valuation and key financial metrics